Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.
about
Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.Estimation of Symptom Severity During Chemotherapy From Passively Sensed Data: Exploratory Study.Women with breast cancer report substantially more disease- and treatment-related side or late effects than registered by clinical oncologists: a cross-sectional study of a standard follow-up program in an oncological department.
P2860
Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Patient-reported outcomes (PRO ...... nd translational implications.
@en
type
label
Patient-reported outcomes (PRO ...... nd translational implications.
@en
prefLabel
Patient-reported outcomes (PRO ...... nd translational implications.
@en
P2093
P2860
P50
P1476
Patient-reported outcomes (PRO ...... nd translational implications.
@en
P2093
Aleksandra Pesic
Andreas Hartkopf
Christof Sohn
Christoph Domschke
Florian Schuetz
Florin-Andrei Taran
Luka Katic
Markus Wallwiener
Martin Teufel
Peyman Hadji
P2860
P2888
P304
P356
10.1007/S00520-016-3437-2
P577
2016-10-17T00:00:00Z